Treatment of Proximal Humerus Neck Fracture in a 59-Year-Old Female
For a 59-year-old female with a proximal humerus neck fracture, conservative management with analgesia, early mobilization, and calcium/vitamin D supplementation is the primary treatment approach for most fracture patterns, while operative intervention should be reserved for significantly displaced multi-part fractures or fracture-dislocations. 1, 2
Acute Fracture Management
Initial Treatment Decision
- Most proximal humerus fractures should be managed conservatively with pain control, brief immobilization (sling for comfort), and early mobilization as pain allows 1, 2
- Conservative therapy is appropriate since most acute symptoms subside over 6-8 weeks as the fracture heals 3
- Consultation with an orthopedic surgeon is indicated only if there are multiple fracture fragments with extensive displacement 2
Operative Indications (Specific Criteria)
Surgical intervention should be considered for:
- Three-part or four-part fractures with significant displacement where anatomic reconstruction cannot be obtained conservatively 1
- Fracture-dislocations of the humeral head 4
- Ischemic humeral head or when anatomic reduction is impossible 1
Surgical Options When Indicated
- For displaced multi-part fractures in osteoporotic bone: Internal fixation using thin, flexible implants that allow load-sharing (not load-bearing) with metaphyseal elastic buttressing is preferred when head preservation is possible 1
- For irreparable fractures or ischemic humeral head: Hemiarthroplasty or reverse total shoulder arthroplasty is the method of choice 4, 1
Critical Osteoporosis Evaluation (Mandatory)
This fracture is a red flag for underlying osteoporosis and requires systematic evaluation regardless of fracture treatment chosen. 3, 5, 6
Immediate Diagnostic Workup
- Obtain DXA scan of spine and hip to measure bone mineral density 3, 5
- Perform vertebral imaging to identify silent vertebral compression fractures 5
- Calculate 10-year fracture risk using FRAX (WHO Fracture Risk Assessment Tool) 3, 5
- Assess clinical risk factors: prior fractures, falls, low body weight, smoking, alcohol use 5
Osteoporosis Treatment Thresholds
Pharmacologic treatment is indicated if:
- T-score ≤ -2.5 at spine or hip 3
- FRAX 10-year risk ≥20% for major osteoporotic fracture OR ≥3% for hip fracture 3, 5
- History of fragility fracture (which this patient now has) 3, 5
Recommended Osteoporosis Treatment
First-line pharmacologic therapy: Oral bisphosphonate (alendronate or risedronate) 3
Alternative therapies if oral bisphosphonates are not appropriate (in order of preference):
All patients require:
- Calcium 1,000-1,200 mg/day 3
- Vitamin D 600-800 IU/day (target serum level ≥20 ng/mL) 3
- Weight-bearing exercise as tolerated 3
- Smoking cessation and alcohol limitation 3
Implementation Strategy
- Establish a Fracture Liaison Service (FLS) approach with a dedicated coordinator to ensure osteoporosis evaluation is completed, treatment is initiated, and primary care physician is notified 3, 5
- This systematic approach significantly improves treatment implementation and reduces subsequent fracture risk 3, 5
Critical Pitfalls to Avoid
- Do not delay osteoporosis evaluation: The risk of subsequent fracture is highest immediately after the initial fracture, with a 20% risk of another vertebral fracture within 12 months 3, 5
- Do not rely solely on BMD: Proximal humerus bone density is often underestimated by standard DXA, and cortical index measurements show many patients are at fracture risk despite non-critical femoral densitometry values 7
- Do not use bulky, stiff implants if surgery is needed: In osteoporotic bone, thin and flexible load-sharing constructs with metaphyseal buttressing are mandatory to prevent fixation failure 1
- Do not prescribe prolonged bed rest: Even 10 days of bed rest causes 15% loss of lower extremity strength and 10-15% loss of aerobic capacity, equivalent to a decade of age-related decline 3
- Do not overlook secondary causes of osteoporosis: Up to 30% of women with osteoporosis have underlying secondary causes requiring specific treatment 5